| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/07/2007 | CN1298316C Pharma ceutical formulation containing LTB4 antagonist |
| 02/07/2007 | CN1298314C Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 02/06/2007 | US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid |
| 02/06/2007 | US7173056 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 02/06/2007 | US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands |
| 02/06/2007 | US7173043 Heteroaromate OSC inhibitors |
| 02/06/2007 | US7173042 Quinoline inhibitors of cGMP phosphodiesterase |
| 02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 02/06/2007 | US7173038 Treatment of diseases such as cancer or arthritis |
| 02/06/2007 | US7173037 Compounds for trearment of cardiovascular disorders and hypotensive agents |
| 02/06/2007 | US7173028 Pyrimidine derivatives |
| 02/06/2007 | US7173027 Provide a physiological effect to a subject |
| 02/06/2007 | US7173025 Compounds for use as anticoagulants for treatment of arteries in brains and factor x inhibitors |
| 02/06/2007 | US7172892 Exhibit protease activity as a single chain or as an activated two chain form; use of polypeptides to identify compounds that modulate the protease activity thereof and as tumor markers |
| 02/06/2007 | US7172876 Method of screening therapeutic agents for nerve degeneration associated diseases |
| 02/06/2007 | US7172871 Methods and compositions for modulating axonal outgrowth of central nervous system neurons |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/06/2007 | CA2173207C Levobupivacaine and its use as an anaesthetic in patients having or disposed to depressed myocardial contractility |
| 02/01/2007 | WO2007014051A2 Use of amylin and amylin agonists as cardioprotective or myoprotective agents |
| 02/01/2007 | WO2007013964A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors |
| 02/01/2007 | WO2007013845A1 Use of 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate n-oxide against stroke-in-evolution |
| 02/01/2007 | WO2007013843A1 Use of 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate n-oxide against myocardial ischaemia |
| 02/01/2007 | WO2007013691A1 Spiro-cyclic compound |
| 02/01/2007 | WO2007013615A1 Container-packed black coffee beverage |
| 02/01/2007 | WO2007013588A1 Strain of turkey tail mushroom, extract from the same, and use of the same |
| 02/01/2007 | WO2007013586A1 Novel peptide |
| 02/01/2007 | WO2007013426A1 Process for production of fermented milk and fermented milk beverage/food |
| 02/01/2007 | WO2007013078A2 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology |
| 02/01/2007 | WO2007012764A2 Cell/ligand marking system, wherein the marker is of eph type, cell material comprising said system, method for preparing same and proangiogenetic use |
| 02/01/2007 | WO2007012422A1 Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors |
| 02/01/2007 | WO2007012421A1 Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 02/01/2007 | WO2006131586B1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 02/01/2007 | WO2005063745A9 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
| 02/01/2007 | WO2003058203A3 Extended glucagon-like peptide-1 analogs |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070027304 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 02/01/2007 | US20070027198 Crystal of heterocyclic compound |
| 02/01/2007 | US20070027197 Pharmaceutical composition and method for the treatment of diseases using HMG-CoA reductase inhibitors and insulin secretion enhancers or sensitizers |
| 02/01/2007 | US20070027196 Activator of peroxisome proliferator-activated receptor delta |
| 02/01/2007 | US20070027174 Phenylalanine Enamide Derivatives |
| 02/01/2007 | US20070027157 Quinoxalinone-3-one derivatives as orexin receptor antagonists |
| 02/01/2007 | US20070027149 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors |
| 02/01/2007 | US20070027145 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
| 02/01/2007 | US20070027138 Derivatives and analogs of galanthamine |
| 02/01/2007 | US20070027124 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070027123 Administering an estrogen receptor for treatment of osteoporosis, breast cancer, hypercholesteremia, hyperlipidemia or artheriosclerosis by administering estrogen modulators |
| 02/01/2007 | US20070027122 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070027076 Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 02/01/2007 | US20070026494 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026470 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026457 Screening method |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026081 Microparticles |
| 02/01/2007 | US20070026036 Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | DE102005034406A1 Neue Salze von Rosiglitazon New salts of rosiglitazone |
| 02/01/2007 | CA2617042A1 Spiro-cyclic compound |
| 02/01/2007 | CA2616789A1 Process for production of fermented milk and fermented milk beverage/food |
| 02/01/2007 | CA2616150A1 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology |
| 02/01/2007 | CA2615946A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors |
| 02/01/2007 | CA2615663A1 Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors |
| 02/01/2007 | CA2615577A1 Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 01/31/2007 | EP1748048A1 Imidazopyridine compound |
| 01/31/2007 | EP1747780A1 Drug for prevention or treatment of diabetes |
| 01/31/2007 | EP1747778A1 Antifatigue composition |
| 01/31/2007 | EP1747199A1 Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 01/31/2007 | EP1746982A2 Histone deacetylases inhibitors against hyperlipidaemias, atherosclerosis and cardiovascular diseases |
| 01/31/2007 | EP1509516B1 Inhibitors of the gpib -vwf interaction, their preparation and use |
| 01/31/2007 | EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 01/31/2007 | CN2863110Y Double-pellet soft capsule |
| 01/31/2007 | CN1906188A Phenyl-[4-(3-phenyl-1H-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as IGF-1R inhibitors |
| 01/31/2007 | CN1906182A Nitrooxyderivatives of antihypertensive drugs |
| 01/31/2007 | CN1906167A Novel pyridine derivative and pyrimidine derivative (2) |
| 01/31/2007 | CN1906166A Novel pyridine derivative and pyrimidine derivative (1) |
| 01/31/2007 | CN1905901A Erythrocyte function modifying substance |
| 01/31/2007 | CN1905882A Vascular intimal hyperplasia inhibitor |
| 01/31/2007 | CN1905877A Pharmaceutical composition for promoting angiogenesis |
| 01/31/2007 | CN1905876A Use of dipeptidyl peptidase IV inhibitors |
| 01/31/2007 | CN1905875A The use of quaternary pyridinium salts as vasoprotective agents |
| 01/31/2007 | CN1904059A Production method of konjak mannose using cellulase |
| 01/31/2007 | CN1903867A New crystalline type 3,4',5-trihydroxy stilbene-3-beta-D-glucocide |
| 01/31/2007 | CN1903365A Drug-carried nanometer particles, and its preparing process for preparing medicien prepn. for anti-restenosis of blood-vessel |
| 01/31/2007 | CN1903364A Medicine composition contg. inhibitor of angiotonase and phenoxy acid compounds |
| 01/31/2007 | CN1903342A Extractive of flowers and leaves of pseudo-ginseng, prepn. method, quality control method and application thereof |
| 01/31/2007 | CN1903322A Medicine for treating myocarditis |
| 01/31/2007 | CN1903314A Traditional Chinese medicine composition for treating head-ache, ahypnia, palpitate and feeble, and its prepn. method |
| 01/31/2007 | CN1903289A Gel for treating hemorrhoidal anus and rectum diseases, and its prepn. method |
| 01/31/2007 | CN1903275A External use medicinal liquid for treating sore |
| 01/31/2007 | CN1903268A Medicine composition for treating atherosclerosis and its prepn. method |
| 01/31/2007 | CN1903267A Traditional Chinese medicine decoction Buyang Xiaoshuan Huanwu Tang for tonifying yang and dissolving thrombus |
| 01/31/2007 | CN1903261A Method for processing monkshood |
| 01/31/2007 | CN1903260A Traditional Chinese medicine prepns. for treating ischemic cerebrovascular disease |
| 01/31/2007 | CN1903252A Fingerprint analysis method for traditional Chinese medicine composition to treat cardiovascular disease |
| 01/31/2007 | CN1903251A Shuangshen phenol glucoside injection, prepn. method and use thereof |
| 01/31/2007 | CN1903250A Method for extraction and separation of red rooted salvia |
| 01/31/2007 | CN1903245A Dripping pills of Naoxingqing for treating cerebro-cardio-vascular disease and preparing process thereof |
| 01/31/2007 | CN1903243A Guhong control-release tablets and prepn. method therefor |